Author:
Brahmaiah Dabbugoddu,Kanaka Durga Bhavani Anagani,Aparna Pasula,Sampath Kumar Nangunoori,Solhi Hélène,Le Guevel Rémy,Baratte Blandine,Ruchaud Sandrine,Bach Stéphane,Singh Jadav Surender,Raji Reddy Chada,Roisnel Thierry,Mosset Paul,Levoin Nicolas,Grée René
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference65 articles.
1. New opportunities for kinase drug repurposing and target discovery;Knapp;Br. J. Can.,2018
2. (a) Ferguson FM, Gray NS, Kinase inhibitors: the road ahead. Nature Reviews Drug Discovery2018;17:353-377; (b) Laufer S, Briner K, Bajorath J, Georg GI, Wang S, New horizons in drug discovery–understanding and advancing kinase inhibitors. J. Med. Chem. 2020;63:7921-7922.
3. PKIDB: A curated, annotated and updated database of protein kinase inhibitors in clinical trials;Carles;Molecules,2018
4. Properties of FDA-approved small molecule protein kinase inhibitors;Roskoski;Pharmacol Res,2019
5. Targeting RNA splicing for disease therapy;Havens;Wiley Interdiscip Rev RNA,2013
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献